Integral Molecular reaches milestone in I-O target discovery collaboration with Daiichi Sankyo

(Integral Molecular) Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, announced that it has successfully reached the first milestone in its collaboration with Daiichi Sankyo Co., Ltd. to discover new immuno-oncology (I-O) therapeutic targets.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2XfXZFA